| Ian Dennis Holgado, DO | |
|
93 W Devon Dr, Suite 100, Exton, PA 19341-3062 | |
| (610) 321-0200 | |
| (610) 594-2625 |
| Full Name | Ian Dennis Holgado |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 93 W Devon Dr, Exton, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790723443 | NPI | - | NPPES |
| 102434521 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS012508 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Main Line Health Home Care & Hospice - Home Health | Radnor, PA | Home health agency |
| Penn Medicine Home Health | Bala cynwyd, PA | Home health agency |
| Chester County Hospital | West chester, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pentahealth, Llc | 9537586672 | 59 |
News Archive
Researchers from St. Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with researchers at McMaster University in Canada, are reportedly the first to discover how the type 2 diabetes drug metformin actually works, providing a molecular understanding that could lead to the development of more effective therapies. Mass spectrometry technologies from AB SCIEX, a global leader in analytical technologies, played a critical role in the analysis that led to this breakthrough finding.
Up to 30% of the world's population is infected with Tuberculosis (TB), but in many areas of the world, TB diagnosis still relies on insensitive, poorly standardized, and time-consuming methods. A new diagnostic tool, endorsed by the World Health Organization (WHO), may change that. Dr. Thomas Bodmer shows how it's done in the Journal of Visualized Experiments (JoVE).
AstraZeneca today announced that the European Commission (EC) has granted conditional marketing authorisation for TAGRISSO™ (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).
The U.S. obesity prevalence increased from 13 percent to 32 percent between the 1960s and 2004, according to researchers at the Johns Hopkins Bloomberg School of Public Health Center for Human Nutrition.
› Verified 5 days ago
| Entity Name | Gateway Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770659476 PECOS PAC ID: 5294707634 Enrollment ID: O20040806001106 |
News Archive
Researchers from St. Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with researchers at McMaster University in Canada, are reportedly the first to discover how the type 2 diabetes drug metformin actually works, providing a molecular understanding that could lead to the development of more effective therapies. Mass spectrometry technologies from AB SCIEX, a global leader in analytical technologies, played a critical role in the analysis that led to this breakthrough finding.
Up to 30% of the world's population is infected with Tuberculosis (TB), but in many areas of the world, TB diagnosis still relies on insensitive, poorly standardized, and time-consuming methods. A new diagnostic tool, endorsed by the World Health Organization (WHO), may change that. Dr. Thomas Bodmer shows how it's done in the Journal of Visualized Experiments (JoVE).
AstraZeneca today announced that the European Commission (EC) has granted conditional marketing authorisation for TAGRISSO™ (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).
The U.S. obesity prevalence increased from 13 percent to 32 percent between the 1960s and 2004, according to researchers at the Johns Hopkins Bloomberg School of Public Health Center for Human Nutrition.
› Verified 5 days ago
| Entity Name | Pentahealth, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639787740 PECOS PAC ID: 9537586672 Enrollment ID: O20200903000805 |
News Archive
Researchers from St. Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with researchers at McMaster University in Canada, are reportedly the first to discover how the type 2 diabetes drug metformin actually works, providing a molecular understanding that could lead to the development of more effective therapies. Mass spectrometry technologies from AB SCIEX, a global leader in analytical technologies, played a critical role in the analysis that led to this breakthrough finding.
Up to 30% of the world's population is infected with Tuberculosis (TB), but in many areas of the world, TB diagnosis still relies on insensitive, poorly standardized, and time-consuming methods. A new diagnostic tool, endorsed by the World Health Organization (WHO), may change that. Dr. Thomas Bodmer shows how it's done in the Journal of Visualized Experiments (JoVE).
AstraZeneca today announced that the European Commission (EC) has granted conditional marketing authorisation for TAGRISSO™ (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).
The U.S. obesity prevalence increased from 13 percent to 32 percent between the 1960s and 2004, according to researchers at the Johns Hopkins Bloomberg School of Public Health Center for Human Nutrition.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ian Dennis Holgado, DO 412 Creamery Way, Suite 400, Exton, PA 19341-2551 Ph: (610) 594-7590 | Ian Dennis Holgado, DO 93 W Devon Dr, Suite 100, Exton, PA 19341-3062 Ph: (610) 321-0200 |
News Archive
Researchers from St. Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with researchers at McMaster University in Canada, are reportedly the first to discover how the type 2 diabetes drug metformin actually works, providing a molecular understanding that could lead to the development of more effective therapies. Mass spectrometry technologies from AB SCIEX, a global leader in analytical technologies, played a critical role in the analysis that led to this breakthrough finding.
Up to 30% of the world's population is infected with Tuberculosis (TB), but in many areas of the world, TB diagnosis still relies on insensitive, poorly standardized, and time-consuming methods. A new diagnostic tool, endorsed by the World Health Organization (WHO), may change that. Dr. Thomas Bodmer shows how it's done in the Journal of Visualized Experiments (JoVE).
AstraZeneca today announced that the European Commission (EC) has granted conditional marketing authorisation for TAGRISSO™ (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).
The U.S. obesity prevalence increased from 13 percent to 32 percent between the 1960s and 2004, according to researchers at the Johns Hopkins Bloomberg School of Public Health Center for Human Nutrition.
› Verified 5 days ago
Mrs. Corinne Ruggiero, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 605 Gordon Dr, Exton, PA 19341 Phone: 610-363-0248 Fax: 610-363-4004 | |
Jason E. Conwell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 154 Exton Square Mall, Exton, PA 19341 Phone: 484-565-8500 Fax: 610-280-1595 | |
Michael Anthony Mcguire, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 770 W Lincoln Hwy, Exton, PA 19341 Phone: 610-269-1372 Fax: 610-269-6951 | |
Dr. Marina V. Makous, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 430 Exton Commons, Exton, PA 19341 Phone: 484-876-1362 Fax: 610-363-6131 | |
John N Khalifa, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 93 W Devon Dr, Suite 100, Exton, PA 19341 Phone: 610-321-0200 Fax: 610-594-2625 | |
Emilia Sophia Kleinman, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 154 Exton Square Mall, Exton, PA 19341 Phone: 484-565-8500 Fax: 610-280-1595 | |
Meghan Elizabeth Wesolowski, CRNP Family Medicine Medicare: Medicare Enrolled Practice Location: 860 Springdale Dr Ste 100, Exton, PA 19341 Phone: 610-524-3703 Fax: 610-524-5990 |